HyperScribe All in One mRNA Synthesis Kit: Assay Logic
2026-08-22
The HyperScribe All in One mRNA Synthesis Kit Plus 1 enables a controlled path from T7 transcription to ARCA capping, nucleotide modification, DNase treatment, and poly(A) tailing. This guide interprets recent neoantigen vaccine research to show how transcript architecture should shape translation, immunogenicity, and quality-control decisions.
How Cell Division Refines Drosophila Tissue Boundaries
2026-08-21
Castle and colleagues reveal that cell division has a dual mechanical role at the Drosophila mesectoderm–ectoderm boundary: proliferation can challenge boundary integrity when actomyosin tension is reduced, yet it can also sharpen the interface by increasing ectodermal fluidity. Mathematical modelling, quantitative microscopy, cell tracking, and laser ablation connect these behaviors to reduced junctional tension and enhanced cell rearrangement.
Ibrutinib, CSK Inhibition, and Atrial Fibrillation
2026-08-20
Xiao and colleagues used electrophysiology, chemoproteomics, cardiac genetics, pharmacology, and pharmacovigilance to identify C-terminal Src kinase inhibition as the mechanism linking ibrutinib to atrial fibrillation. Their findings separate Bruton tyrosine kinase efficacy from an off-target cardiovascular liability and provide a framework for evaluating kinase-inhibitor safety.
Dimethyloxalylglycine (DMOG): Protocol Guide
2026-08-20
Dimethyloxalylglycine (DMOG), SKU A4506, provides a practical way to induce hypoxia-inducible factor stabilization in controlled cell and preclinical studies without changing ambient oxygen. It is intended for research on oxygen sensing, hypoxia signaling, and selected inflammation models, not for diagnostic, therapeutic, or clinical use.
CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia
2026-08-19
Liao et al. identify a calcium-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and in vitro experiments place the trigeminal ganglion–Merkel cell axis at the center of peripheral sensitization and suggest mechanistic targets for trigeminal neuralgia research.
Berbamine hydrochloride: NF-κB Activity Inhibitor
2026-08-19
Berbamine hydrochloride supports pathway-oriented cancer research across leukemia and hepatocellular carcinoma models, combining cytotoxicity profiling with STAT3, calcium, NF-κB, and ferroptosis-focused readouts. This workflow translates the METTL16-SENP3-LTF findings into practical assay decisions while clearly separating established evidence from testable hypotheses.
Metronidazole: OAT3 Inhibition for Research
2026-08-18
Metronidazole, also known as 2-(2-methyl-5-nitroimidazol-1-yl)ethanol, is a nitroimidazole antibiotic and an in vitro OAT3 inhibitor. Its transporter activity supports research on organic anion uptake, methotrexate transport, and drug-drug interaction modulation, while its antimicrobial activity supports anaerobic bacteria and protozoa studies.
Carbapenemase Transmission in Resistant E. cloacae
2026-08-18
A 2025 BMC Microbiology study integrated gene localization, antimicrobial susceptibility, plasmid conjugation, mobile-element analysis, and ERIC-PCR typing to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. Its findings identify plasmid-associated blaNDM-1 as a highly transferable resistance determinant and show that both horizontal gene transfer and clonal dissemination contribute to regional CREC transmission.
Deferasirox Fe3+ Chelate in Cell Assays
2026-08-17
This scenario-driven guide explains how Deferasirox Fe3+ chelate, SKU A3355, can support controlled iron-metabolism and cell-stress experiments while highlighting solvent, interpretation, and replication safeguards. It connects product specifications with recent evidence linking ferritinophagy, lysosomal acidification, and nutrient-stress cell death.
Pam3CSK4 TFA: TLR1/2 Assay Workflows
2026-08-17
Build reproducible TLR1/2 stimulation assays with Pam3CSK4 TFA for cytokine profiling, pathway comparison, and innate immune research. The workflow connects controlled ex vivo activation with translational questions such as IL-17A responses in GBS-colonized mother–newborn cohorts.
Toremifene in Breast Cancer: 20 Years of Data
2026-08-16
This review synthesizes two decades of clinical experience with toremifene, emphasizing its efficacy, safety, distinct pharmacokinetics, and potential role in postmenopausal estrogen receptor-positive breast cancer. Its main contribution is a clinically contextualized comparison with tamoxifen and aromatase inhibitors rather than a new clinical trial or claim of universal superiority.
Cefazedone (Refosporen): From Mechanism to Translation
2026-08-15
Cefazedone, also known as Refosporen, offers translational researchers a useful bridge between penicillin-binding protein biology, reproducible antibacterial testing in vitro, and exposure-guided development. This thought-leadership perspective interprets its mechanism, PK/PD evidence, formulation considerations, and clinical relevance while distinguishing exploratory research signals from validated therapeutic conclusions.
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-08-15
The reference study identifies an O-GlcNAc–HUWE1–TfR1 pathway that connects nutrient-sensitive protein modification with iron uptake, ferroptosis, and trophoblast syncytialization in preeclampsia. Its experimental framework combines placental analysis, O-GlcNAc modification proteomics, trophoblast models, mechanistic ubiquitination assays, and mouse outcomes, providing a useful blueprint for O-GlcNAcylation research in placental biology.
Native Protein Gel Electrophoresis: A Decision Guide
2026-08-14
Native protein gel electrophoresis separates proteins without SDS, helping researchers preserve conformation, complexes, and activity. This decision-focused guide explains when the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) is appropriate and how its logic complements modern functional disease models.
Syringin Enhances Sunitinib Response in RCC
2026-08-14
The reference study identifies syringin as a potential adjunct treatment for renal cell carcinoma (RCC), combining computational target discovery with cell-based validation to implicate the EGFR/PI3K/Akt pathway. Its most practical finding is that syringin suppresses RCC-related phenotypes and increases cellular sensitivity to sunitinib, while the evidence remains preclinical and requires validation in more representative models.
479 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page